SEC Form 3 · accession 0000899243-18-017272
Eidos Therapeutics, Inc. · EIDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Uma Sinha
Officer — Chief Scientific Officer
Period of report
Jun 19, 2018
Accepted (ET)
Jun 19, 2018 · 9:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001731831
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 353,231 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24.1 - Power of Attorney